Abstract
Review presents basic mechanisms of molecular interaction between beta 2-adrenoreceptor and its agonists. Practical aspects of differences in pharmacokinetic profiles of short and long acting beta-agonists are analysed with special attention paid to selected clinical situations when their therapeutic potential might be affected and risk of side effect increased.
Publication types
-
Editorial
-
English Abstract
-
Review
MeSH terms
-
Adrenergic beta-2 Receptor Agonists*
-
Adrenergic beta-Agonists / adverse effects*
-
Adrenergic beta-Agonists / pharmacology*
-
Adrenergic beta-Agonists / therapeutic use
-
Dose-Response Relationship, Drug
-
Drug Tolerance
-
Humans
-
Pulmonary Disease, Chronic Obstructive / drug therapy
-
Pulmonary Disease, Chronic Obstructive / metabolism
-
Risk Factors
Substances
-
Adrenergic beta-2 Receptor Agonists
-
Adrenergic beta-Agonists